In the News

1861 News Items found
Epigenetics
Q&A
An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.
New treatments developed at MSK focus on both common and rare cancers.
In the Clinic
An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.
Neurons created from embryonic stem cells
In the Lab
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
Pictured: Viviane Tabar
In the Lab
Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.
MSK investigators Michael Berger and David Solit.
Finding
A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.
Cancer biologist Andrea Ventura
In the Lab
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
A student asks a question at last year’s "Major Trends” seminar.
Event
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
Pictured: Pseudomonas aeruginosa
In the Lab
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
DNA wrapped around histones
Decoder
What Is Epigenetics?
Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.